You can read daily news of Global New Light of Myanmar using mobile applications. Download now!

August 23, 2019

MPF will manufacture new cancer drugs, HIV drugs

Myanmar Pharmaceutical Factory (MPF), formerly known as Burma Pharmaceutical Industry (BPI), will manufacture new cancer and anti-HIV drugs in the 2018-2019 fiscal year, said U Ko Ko Aung, Managing Director of MPF.
He was speaking at the medical conference held in the meeting hall of MPF Insein factory on 23 January.
“We are planning to manufacture new products in the coming fiscal year. We will conduct research for production, especially on medication to relieve pain from cancer and anti-HIV drugs. By increasing product manufacturing, we can reduce the number of medicines bought from abroad,” he added.
There are two pharmaceutical factories in the country: MPF Insein and Kyaukse. MPF is producing some 148 products this fiscal year (FY). Its production value increased up to Ks50 billion this FY.
The Ministry of Health and Sports has bought products worth Ks32 billion from MPF. Also, MPF distributed products worth Ks18 billion to the Ministry of Defence; Ministry of Labour, Immigration and Population; and other sales representatives.
MPF has constructed a new building to manufacture more products and meet the World Health Organisation’s guidelines on genetically modified organisms. Besides this, MPF has changed the packaging on its BPI-brand pharmaceutical products.
The media conference was attended by officials of MPF, the Ministry of Health and Sports, professors and office superintendents, as well as doctors and officials from the food and drug administration. —Min Thit (MNA)

Comments

Related posts